Related Experiment Video
Updated: Oct 20, 2025

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
Published on: March 30, 2015
Hypercalcemia and Renal Mass: A Diagnostically Challenging Case.
Sunita Karki1, Sneha Galiveeti2, Vivien Leung2
1Internal Medicine, BronxCare Health System, Bronx, USA.
This study presents a rare case of severe hypercalcemia in a renal cell carcinoma patient, driven by elevated vitamin D metabolites rather than typical humoral hypercalcemia of malignancy. It emphasizes considering multiple causes for hypercalcemia in cancer patients.
Area of Science:
- Endocrinology
- Oncology
Background:
- Hypercalcemia of malignancy is common, often due to parathyroid hormone-related peptide (PTHrP).
- 1,25-dihydroxyvitamin D [1,25(OH)2D]-mediated hypercalcemia is less frequent, typically seen in lymphoma.
Observation:
- A 77-year-old male with suspected renal cell carcinoma (RCC) presented with severe hypercalcemia (18.7 mg/dL).
- Initial assessment suggested humoral hypercalcemia of malignancy (HHM), but further tests revealed normal parathyroid hormone, low PTHrP, and high 25-hydroxyvitamin D and 1,25(OH)2D levels.
Findings:
- Bisphosphonate therapy was ineffective.
- Corticosteroid treatment led to reduced serum calcium levels, indicating a role for vitamin D metabolites.
Implications:
- This case underscores the importance of a broad differential diagnosis for severe hypercalcemia in cancer patients.
- It highlights the potential for calcitriol-mediated hypercalcemia in renal cell carcinoma, necessitating consideration of vitamin D pathways.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi I: Introduction
Chronic Kidney Disease II: Clinical Manifestations

